HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The white matter hyperintensities within the cholinergic pathways and cognitive performance in patients with Parkinson's disease after bilateral STN DBS.

AbstractBACKGROUND:
White matter hyperintensities (WMHs) in the cholinergic pathways are associated with cognitive impairment in Parkinson's disease (PD). This study aimed to investigate the role of WMHs within the cholinergic pathways in cognitive performance following bilateral subthalamic nucleus deep brain stimulation (STN DBS) in patients with PD.
METHODS:
38 patients with PD who underwent bilateral STN DBS were assessed using the Cholinergic Pathways Hyperintensities Scale (CHIPS) with magnetic resonance imaging before surgery. Their cognitive statuses were evaluated pre-surgically and 6 months, 1 year, and 2 years post operation. The correlations between the CHIPS score and cognitive performance were analyzed. The differences in cognitive performance before and after the surgery between the high-CHIPS and low-CHIPS groups were also compared.
RESULTS:
The CHIPS score in patients with PD negatively correlated with the general cognition assessed using Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) both at baseline and after DBS. No correlation was found between the CHIPS score and the change of MMSE and MoCA scores after DBS. No significant difference was observed in the change in cognitive performance after the surgery between the high and low-CHIPS groups.
CONCLUSION:
The severity of cholinergic WMHs was correlated with the cognition in patients with PD both before and after the STN DBS. However, it does not correlate with the cognitive change in patients with PD after bilateral STN-DBS.
AuthorsYanmei Liu, Lei Wu, Chao Yang, Wenbiao Xian, Yifan Zheng, Caixia Zhang, Guixun Hong, Lulu Jiang, Zhiyun Yang, Zhong Pei, Jinlong Liu, Ling Chen
JournalJournal of the neurological sciences (J Neurol Sci) Vol. 418 Pg. 117121 (Nov 15 2020) ISSN: 1878-5883 [Electronic] Netherlands
PMID32950863 (Publication Type: Journal Article)
CopyrightCopyright © 2020. Published by Elsevier B.V.
Chemical References
  • Cholinergic Agents
Topics
  • Cholinergic Agents
  • Cognition
  • Deep Brain Stimulation
  • Humans
  • Parkinson Disease (complications, diagnostic imaging, therapy)
  • White Matter (diagnostic imaging)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: